Sign Up Today and Learn More About Akston Biosciences Stock
Invest in or calculate the value of your shares in Akston Biosciences or other pre-IPO companies through EquityZen's platform.
Akston Biosciences Stock
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
About Akston Biosciences Stock
Founded
2011
Headquarters
Beverly, MA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. It was founded in 2011 and headquartered in Beverly, Massachusetts.
Akston Biosciences Press Mentions
Stay in the know about the latest news on Akston Biosciences
Dechra Purchases Veterinary Insulin Programs from Akston Biosciences
businesswire • Aug 05, 2024
Photo - Dr. Linda Rhodes Joins Akston Biosciences' Board of Directors
businesswire • Jun 24, 2024
Dr. Linda Rhodes Joins Akston Biosciences' Board of Directors
finance • Jun 24, 2024
Dr. Linda Rhodes Joins Akston Biosciences’ Board of Directors
biospace • Jun 17, 2024
Akston Biosciences' AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform's Versatility
businesswire • May 05, 2024
Akston Biosciences Management
Leadership team at Akston Biosciences
Co-founder, President, and CEO
Todd C. Zion
Join now and verify your accreditation status to gain access to:
- Akston Biosciences current valuation
- Akston Biosciences stock price
- Available deals in Akston Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Akston Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Akston Biosciences through EquityZen funds. These investments are made available by existing Akston Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Akston Biosciences stock?
Shareholders can sell their Akston Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
